Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 6/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.38 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.38 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.38 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14811633 | 0.98 | ALDH1A1 (0.39) | ALDH1A1TSHRKIF11CES2CES1 | |
| Hydrochloric Acid SCHEMBL9938710 | 0.96 | KIF11 (0.40) | ALDH1A1TSHRKIF11CES2CES1 | |
| SCHEMBL23145206 | 0.92 | AHR (0.35) | ALDH1A1TSHRKIF11CES2CES1 | |
| SCHEMBL2557952 | 0.82 | — | — | |
| SCHEMBL2548631 | 0.80 | TSHR (0.48) | ALDH1A1TSHRKIF11 | |
| SCHEMBL3817848 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRKIF11CES2CES1 | |
| Hydrochloric Acid SCHEMBL29591258 | 0.78 | TSHR (0.46) | ALDH1A1TSHRKIF11 | |
| SCHEMBL29670197 | 0.78 | TSHR (0.46) | ALDH1A1TSHRKIF11 | |
| SCHEMBL2550800 | 0.76 | CES2 (0.38) | KIF11CES2 | |
| SCHEMBL2550798 | 0.76 | MEN1 (0.35) | ALDH1A1TSHRKIF11TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105392791-B | Improved process for preparing chlorinated biphenylanilides and biphenylanilides | 拜耳作物科学股份公司 | 2019-02-22 | — | — | CN | claimed |
| EP-3024836-B1 | IMPROVED METHOD FOR THE PREPARATION OF CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AG (DE) | 2018-07-11 | — | — | EP | claimed |
| EP-2922813-B1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | FIRMENICH & CIE (CH) | 2016-10-12 | — | — | EP | claimed |
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-09-29 | — | — | US | claimed |
| US-9376365-B2 | Hydrocarbonylation or methoxycarbonylation of 1,3-diene derivatives with palladium complex | FIRMENICH SA (CH) | 2016-06-28 | — | — | US | claimed |
| EP-3024836-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | Bayer CropScience Aktiengesellschaft (DE) | 2016-06-01 | — | — | EP | claimed |
| US-20150299085-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | FIRMENICH SA (CH) | 2015-10-22 | — | — | US | claimed |
| WO-2015011032-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | BAYER CROPSCIENCE AG (DE) | 2015-01-29 | — | — | WO | claimed |
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | BHATTACHARYA SHRABANTI (US) | 2025-12-04 | — | — | US | disclosed |
| CN-119998255-A | Catalytic carboxycarbonylation of olefins to form anhydrides | 北卡罗来纳大学教堂山分校 | 2025-05-13 | — | — | CN | disclosed |
| CN-119735558-A | Preparation method and intermediate of aza-quinolinone derivative | 成都苑东生物制药股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119677765-A | Method for producing antibiotic macrocyclic peptides | 豪夫迈·罗氏有限公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20250051363-A1 | Substituted Pyrazolopyridines | NEURO3 THERAPEUTICS INC (US) | 2025-02-13 | — | — | US | disclosed |
| WO-2025029897-A1 | SUBSTITUTED PYRAZOLOPYRIDINES | NEURO3 THERAPEUTICS, INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| US-7847126-B2 | prepared by reacting phosphorus halide with organomagnesium compound in presence of copper compound; di(tert-butyl)phenylphosphonium tetrafluoroborate, for example | LANXESS DEUTSCHLAND GMBH (DE) | 2010-12-07 | — | — | US | disclosed |
| EP-1354886-B1 | Process for the preparation of tertiary phosphines | SALTIGO GMBH (DE) | 2009-08-26 | — | — | EP | disclosed |
| US-20070299273-A1 | prepared by reacting phosphorus halide with organomagnesium compound in presence of copper compound; di(tert-butyl)phenylphosphonium tetrafluoroborate, for example | LANXESS DEUTSCHLAND GMBH (DE) | 2007-12-27 | — | — | US | disclosed |
| US-7230136-B2 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2007-06-12 | — | — | US | disclosed |
| US-20030229240-A1 | Reacting phosphorus halide with organomagnesium compound in presence of copper compound | LANXESS DEUTSCHLAND GMBH (DE) | 2003-12-11 | — | — | US | disclosed |
| EP-1354886-A1 | Process for the preparation of tertiary phosphines | Bayer Aktiengesellschaft (DE) | 2003-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250368598-A1 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | CA4, CA12, CA14 | ALDH1A1 688/4885TSHR 4615/4885KIF11 2722/4885 |
| US-20250051363-A1 | Substituted Pyrazolopyridines | QDPR, DPYD, P2RX4 | ALDH1A1 729/4885TSHR 2797/4885KIF11 3952/4885 |
| US-20150299085-A1 | HYDROCARBONYLATION OR METHOXYCARBONYLATION OF 1,3-DIENE DERIVATIVES WITH PALLADIUM COMPLEX | PHOSPHO1, PDCD1LG2, PDK2 | ALDH1A1 384/4885TSHR 4460/4885KIF11 3305/4885 |
| US-20160280635-A1 | IMPROVED PROCESS FOR PREPARING CHLORINATED BIPHENYLANILIDES AND BIPHENYLANILINES | CYP2F1, CYP1A1, CYP4F12 | ALDH1A1 798/4885TSHR 661/4885KIF11 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.